Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 10/25/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Kehinde Adekola MD, MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN | None | None | None | ✔ |
| Larry Anderson, Jr. MD, PhD | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
Celgene Corporation GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
None | ✔ |
| Muhamed Baljevic MD | Amgen Inc. Bristol Myers Squibb Exelixis Inc. Karyopharm Therapeutics |
None | AlphaSights Aptitude Health Case Series on Hematologic Malignancies Atheneum Bristol Myers Squibb Cardinal Health Oncology Summit Coleman Research GLG individual consultations Guidepoint Global Janssen Biotech, Inc. Karyopharm Therapeutics MediCom Worldwide Inc. NCCN 2020 Virtual Congress: Hematologic Malignancies Oncopeptides Inc. Putnam Associates |
None | ✔ |
| Ryan Berardi MSc | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Natalie Callander MD | None | None | None | None | ✔ |
| Erica Campagnaro MD | None | None | None | None | ✔ |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | ✔ |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Eileen Cucinotta | None | None | None | None | ✔ |
| Christopher D'Angelo MD | BeiGene Fate Therapeutics Karyopharm Therapeutics |
TG Therapeutics | None | None | ✔ |
| Srinivas Devarakonda MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Noura Elsedawy MD | None | None | None | Vyriad | ✔ |
| Colleen Erb MSN, AOCNP, CRNP | None | None | None | None | ✔ |
| Alfred Garfall MD | Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
GSK Janssen Pharmaceutica Products, LP |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | ✔ |
| Kelly Godby MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Jens Hillengass MD, PhD | None | Aptitude Health GSK Oncopeptides sanofi-aventis U.S. Skyline |
Amgen Inc. Beijing Medical Award Foundation Curio Science Patient Partners Rapid Payer Response Research to Practice |
None | ✔ |
| Leona Holmberg MD, PhD | Bristol Myers Squibb Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | ✔ |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | ✔ |
| Carol Ann Huff MD | Glenmark / Ichnos | AstraZeneca Pharmaceuticals LP GSK Oncopeptides sanofi-aventis U.S. |
None | None | ✔ |
| Malin Hultcrantz MD, PhD | Amgen Inc. Daiichi- Sankyo Co. GSK |
None | Bristol Myers Squibb | None | ✔ |
| Yubin Kang MD | Apogee Biotech and RedHill Pharmaceutical Co | None | sanofi-aventis U.S. | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol Myers Squibb Carsgen Celgene Corporation GSK MedImmune Inc. Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. BeiGene Bluebird Celgene Corporation Constellation Epizyme GSK Oncopeptides Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Secura Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol Myers Squibb Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
None | None | ✔ |
| Hans Lee MD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Celgene Corporation Genentech, Inc. GSK Immunitis Therapeutics Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Legend Biotech Oncopeptides sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Michaela Liedtke MD | Allogene Bristol Myers Squibb Caelum Celgene Corporation Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Alnylam Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kite Pharma Kura Oncology, Inc. Natera Oncopeptides sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GSK | None | None | ✔ |
| John Murphy | None | None | None | None | ✔ |
| Jim Omel MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Aaron Rosenberg MD | GSK | None | Takeda Pharmaceuticals North America, Inc. | None | ✔ |
| Douglas Sborov MD, MSc | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP |
GSK Janssen Pharmaceutica Products, LP sanofi-aventis U.S. SkylineDX |
GSK Janssen Pharmaceutica Products, LP |
None | ✔ |
| Keith Stockerl-Goldstein MD | BioLIne Caelum Bioscineces GSK Ionis Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | ✔ |